Sex differences in the aging pattern of renin-angiotensin system serum peptidases

Biology of Sex Differences

Volumn 8, Issue 1, 2017, Pages

  Fernandez Atucha A ^a   Izagirre, A ^b   Fraile Bermudez A B ^a   Kortajarena, M ^a   Larrinaga, G ^a   Martinez Lage, P ^b   Echevarria E ^a,c   Gil, J ^a,c  

^a UNIVERSITY OF THE BASQUE COUNTRY UPV EHU   (Spain)

^b Foundation CITA Alzheimer   (Spain)

^c CENTRO DE INVESTIGACIÓN BIOMÉDICA EN RED DE SALUD MENTAL CIBERSAM   (Spain)

Author keywords

Aging; Renin angiotensin system; Serum peptidases; Sex differences

Indexed keywords

PEPTIDE HYDROLASE;

ADULT; AGED; AGING; ANDROPAUSE; BLOOD; COMPARATIVE STUDY; FEMALE; HUMAN; MALE; MENOPAUSE; MIDDLE AGED; PHYSIOLOGY; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; SEXUAL CHARACTERISTICS;

ADULT; AGED; AGING; ANDROPAUSE; FEMALE; HUMANS; MALE; MENOPAUSE; MIDDLE AGED; PEPTIDE HYDROLASES; RENIN-ANGIOTENSIN SYSTEM; SEX CHARACTERISTICS;

EID: 85011396889     PISSN: None     EISSN: 20426410     Source Type: Journal    
DOI: 10.1186/s13293-017-0128-8     Document Type: Article

References (42)

1. Fyhrquist F, Saijonmaa O. Renin-angiotensin system revisited. J Intern Med. 2008;264:224-36.
2. Hamet P. The renin-angiotensin system: where do we stand, and what is the future? Am J Hypertens. 2005;18:125S-6.
3. Chappell MC, Marshall AC, Alzayadneh EM, Shaltout HA, Diz DI. Update on the angiotensin converting enzyme 2-angiotensin (1-7)-MAS receptor axis: fetal programing, sex differences, and intracellular pathways. Front Endocrinol (Lausanne). 2014;4:201. doi: 10.3389/fendo.2013.00201.
4. Romero CA, Orias M, Weir MR. Novel RAAS agonists and antagonists: clinical applications and controversies. Nat Rev Endocrinol. 2015;11:242-52.
5. Paul M, Mehr AP, Kreutz R. Physiology of local renin-angiotensin systems. Physiol Rev. 2006;86:747-803.
6. Schmieder RE, Hilgers KF, Schlaich MP, Schmidt BM. Renin-angiotensin system and cardiovascular risk. Lancet. 2007;369:1208-19.
7. George AJ, Thomas WG, Hannan RD. The renin-angiotensin system and cancer: old dog, new tricks. Nature Rev Cancer. 2010;10:745-59.
8. Wegman-Ostrosky T, Soto-Reyes E, Vidal-Millán S, Sánchez-Corona J. The renin-angiotensin system meets the hallmarks of cancer. J Renin Angiotensin Aldosterone Syst. 2015;16:227-33.
9. Wright JW, Kawas LH, Harding JW. A role for the brain RAS in Alzheimer's and Parkinson's Diseases. Front Endocrinol (Lausanne). 2013;4:158. doi: 10.3389/fendo.2013.00158.
10. Puertas MC, Martínez-Martos JM, Cobo M, Lorite P, Sandalio RM, Palomeque T, et al. Plasma renin-angiotensin system-regulating aminopeptidase activities are modified in early stage Alzheimer's disease and show gender differences but are not related to apolipoprotein E genotype. Exp Gerontol. 2013;48:557-64.
11. Nichols M, Townsend N, Scarborough P, Rayner M. Cardiovascular disease in Europe: epidemiological update. Eur Heart J. 2013;34:3028-34.
12. Siegel RL, Miller KD, Jemal A. Cancer statistics, 2016. CA Cancer J Clin. 2016;66:7-30.
13. Winblad B, Amouyel P, Andrieu S, Ballard C, Brayne C, Brodaty H, et al. Defeating Alzheimer's disease and other dementias: a priority for European science and society. Lancet Neurol. 2016;15:455-532.
14. Larrinaga G, Blanco L, Sanz B, Perez I, Gil J, Unda M, et al. The impact of peptidase activity on clear cell renal cell carcinoma survival. Am J Physiol Renal Physiol. 2012;303:1584-91.
15. Sanz B, Perez I, Beitia M, Errarte P, Fernández A, Blanco L, et al. Aminopeptidase N activity predicts 5-year survival in colorectal cancer patients. J Investig Med. 2015;63:740-6.
16. Hilliard LM, Sampson AK, Brown RD, Denton KM. The "His and Hers" of the renin-angiotensin system. Curr Hypertens. 2013;15:71-9.
17. Rice GI, Jones AL, Grant PJ, Carter AM, Turner AJ, Hooper NM. Circulating activities of angiotensin-converting enzyme, its homolog, angiotensin-converting enzyme 2, and neprilysin in a family study. Hypertension. 2006;48:914-20.
18. Zapater P, Novalbos J, Gallego-Sandín S, Hernández FT, Abad-Santos F. Gender differences in angiotensin-converting enzyme (ACE) activity and inhibition by enalaprilat in healthy volunteers. J Cardiovasc Pharmacol. 2004;43:737-44.
19. Martínez JM, Ramírez MJ, Prieto I, Alba F, Ramírez M. Sex differences and in vitro effects of steroids on serum aminopeptidase activities. Peptides. 1998;19:1637-40.
20. Ramírez-Expósito MJ, Martínez-Martos JM. Hypertension, RAS and gender: what is the role of aminopeptidases? Heart Fail Rev. 2008;13:355-65.
21. Maric-Bilkan C, Manigrasso MB. Sex differences in hypertension: contribution of the renin-angiotensin system. Gend Med. 2012;9:287-91.
22. Burger HG. The endocrinology of the menopause. Maturitas. 1996;23:129-36.
23. Burger HG, Hale GE, Robertson DM, Dennerstein L. A review of hormonal changes during the menopausal transition: focus on findings from the Melbourne Women's Midlife Health Project. Hum Reprod Update. 2007;13:559-65.
24. Murphy PJ, Campbell SS. Sex hormones, sleep, and core body temperature in older postmenopausal women. Sleep. 2007;30:1788-94.
25. Pines A. Male menopause: is it a real clinical syndrome? Climacteric. 2011;14:15-7.
26. Lee Y. Androgen deficiency syndrome in older people. J American Association Nurse Practitioners. 2014;26:179-86.
27. O'Donnell AB, Travison TG, Harris SS, Tenover JL, McKinlay JB. Testosterone, dehydroepiandrosterone, and physical performance in older men: results from the Massachusetts Male Aging Study. J Clin Endocrinol Metab. 2006;91:425-31.
28. Lunenfeld B, Mskhalaya G, Kalinchenko S, Tishova Y. Recommendations on the diagnosis, treatment and monitoring of late-onset hypogonadism in men: a suggested update. Aging Male. 2013;16:143-50.
29. Lunenfeld B, Mskhalaya G, Zitzmann M, Arver S, Kalinchenko S, Tishova Y, Morgentaler A. Recommendations on the diagnosis, treatment and monitoring of hypogonadism in men. Aging Male. 2015;18:5-15.
30. Corona G, Maseroli E, Rastrelli G, Sforza A, Forti G, Mannucci E, Maggi M. Characteristics of compensated hypogonadism in patients with sexual dysfunction. J Sex Med. 2014;11:1823-34.
31. Dubey RK, Oparil S, Imthurn B, Jackson EK. Sex hormones and hypertension. Cardiovasc Res. 2002;53:688-708.
32. Reckelhoff JF. Gender differences in the regulation of blood pressure. Hypertension. 2001;3:1199-208.
33. Kienitz T, Quinkler M. Testosterone and blood pressure regulation. Kidney Blood Press Res. 2008;31:71-9.
34. Chen YF, Meng QC. Sexual dimorphism of blood pressure in spontaneously hypertensive rats is androgen dependent. Life Sci. 1991;48:85-96.
35. Sánchez-Agesta Ortega R, de Saavedra-Alías JM A, Liébana-Cañada A, Sánchez-Muñoz B, Martínez-Martos JM, Ramírez-Expósito MJ. Circulating aminopeptidase activities in men and women with essential hypertension. Curr Med Chem. 2013;20:4935-45.
36. Bausback HH, Churchill L, Ward PE. Angiotensin metabolism by cerebral microvascular aminopeptidase A. Biochem Pharmacol. 1988;37:155-60.
37. Reaux-Le Goazigo A, Iturrioz X, Fassot C, Claperon C, Roques BP, Llorens-Cortes C. Role of angiotensin III in hypertension. Curr Hypertens Rep. 2005;7:128-34.
38. Bodineau L, Frugière A, Marc Y, Claperon C, Llorens-Cortes C. Aminopeptidase A inhibitors as centrally acting antihypertensive agents. Heart Fail Rev. 2008;13:311-9.
39. Marc Y, Llorens-Cortes C. The role of the brain renin-angiotensin system in hypertension: implications for new treatment. Prog Neurobiol. 2011;95:89-103.
40. Santos RA, Ferreira AJ, Simões e Silva AC. Recent advances in the angiotensin-converting enzyme 2-angiotensin (1-7)-Mas axis. Exp Physiol. 2008;93:519-27.
41. Fraga-Silva RA, Da Silva DG, Montecucco F, Mach F, Stergiopulos N, da Silva RF, Santos RA. The angiotensin-converting enzyme 2/angiotensin-(1-7)/Mas receptor axis: a potential target for treating thrombotic diseases. Thromb Haemost. 2012;108:1089-96.
42. Campesi I, Occhioni S, Tonolo G, Cherchi S, Basili S, Carru C, Zinellu A, Franconi F. Ageing/menopausal status in healthy women and ageing in healthy men differently affect cardiometabolic parameters. Int J Med Sci. 2016;13:124-32.